Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

NCT00127855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

409

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Neisseria Meningitidis

Interventions

BIOLOGICAL: Hib-MenCY-TT vaccine (MenHibrix)
BIOLOGICAL: Meningitec®
BIOLOGICAL: ActHIB®
BIOLOGICAL: Infanrix® Penta
BIOLOGICAL: Prevenar®
BIOLOGICAL: Mencevax® ACWY
BIOLOGICAL: PRP (Polyribosyl Ribitol Phosphate)

Sponsor

GlaxoSmithKline